841 results on '"Kubista E"'
Search Results
152. Expression eines funktionellen IL-1-Systems in malignen Brusttumoren: IL-1alpha korreliert mit malignem Phänotyp
153. „Die Klügere sieht nach“
154. Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment
155. IDENTIFICATION OF GENES ASSOCIATED WITH CERVICAL CANCER BY C-DNA ARRAY COMPARISON BETWEEN NORMAL AND MALIGNANT CERVICAL LAVAGE SAMPLES
156. IL-1 SYSTEM AND SEX STEROID RECEPTOR EXPRESSION IN HUMAN BREAST CANCER: IL-1ALPHA PROTEIN SECRETION IS CORRELATED WITH MALIGNANT PHENOTYPE
157. The prognostic influence of body mass index in premenopausal breast cancer patients
158. Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment
159. Pharmacological modulation of IGF serum concentrations as a therapeutic approach to control the growth of malignant breast tumors
160. Nich-invasives Lymphknotenstaging beim Mammakarzinom
161. IL-1α gene expression in human endometrial cancer is independent of ovarian steroid receptor expression
162. Managing menopausal symptoms after breast cancer
163. A high resolution model for the satellite-to-indoor channel.
164. A high resolution model for the aeronautical multipath navigation channel.
165. Statistical modeling of the LMS channel
166. Ka-band propagation measurements and statistics for land mobile satellite applications
167. cDNA microarray application on cervical epithelial cells
168. Comparison of adjuvant endocrine treatment (tamoxifen and goserelin) vs. chemotherapy (CMF) in premenopausal patients with hormone-responsive early breast cancer: Results from the Austrian Breast Cancer Study Group (ABCSG)
169. Early detection of breast cancer by analysis of P43 positive lymphocytes from peripheral blood
170. Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer
171. Identification of women with early breast cancer by analysis of p43 positive lymphocytes from peripheral blood
172. Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
173. Prognostic implications of tumor cell infiltration of the hematopoietic system in pediatric and adult tumor patients
174. Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer
175. Estrogen replacement therapy in women with a history of breast cancer
176. Identification of women with early breast cancer by analysis of p43-positive lymphocytes
177. Growth inhibition by dehydrothyrsiferol - a non-Pgp modulator, derived from a marine red alga - in human breast cancer cell lines.
178. Demands on obstetrical care in the urban environment: Postpartal survey
179. Land mobile satelliteKa-band shadowing statistics in built-up areas for different road orientations
180. Land mobile satellite Ka‐band shadowing statistics in built‐up areas for different road orientations
181. p43 expression on lymphocytes — A marker for early breast cancer in patients with nonpalpable mammographic finding
182. Second- and third-line treament of metastatic breast cancer with gemcitabine
183. Onycholysis in patients treated with docetaxel
184. A methodology for the characterization of environmental effects on global navigation satellite system (GNSS) propagation
185. 99mTc-Tetrofosmin in breast cancer
186. Founding BRCA1 mutations in Austrian HBOC families
187. Hormonersatztherapie nach Mammakarzinom
188. Current standards of breast cancer treatment in Europe
189. Axilläre Metastasen eines primär unbekannten Karzinoms
190. 84 P - Tissue expression and serum levels of HER-2/neu in patients with breast cancer
191. 14 O - New mutation in BRCA 1 gene detected in 3 austrian HBOC families
192. 107 P - Results of a randomized adjuvant breast cancer trial comparing a conventional with a perioperative start of chemotherapy
193. 94 P - Paclitaxel containing high-dose chemotherapy and autologous blood stem cell support for high risk primary breast cancer
194. Ansprüche an die Geburtshilfe in der Großstadt: Präpartale Erhebung
195. 98 O - Tamoxifen +/- short-term chemotherapy in the treatment of node positive, hormone receptor positive breast cancer: 7-year results of a randomized trial including 517 patients
196. 97 P - Low dose, short-term adjuvant chemotherapy in stage I hormone receptor negative breast cancer
197. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study
198. Die Wertigkeit des Faktors „Gefäßinvasion“ für die Prognose des Mammakarzinoms
199. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer
200. Ansprüche an die Geburtshilfe in der Großstadt
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.